Across TCGA pan-cancer cohorts, C10orf120 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated C10orf120 data layer compared with 12 for mass-spec protein.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher C10orf120 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C10orf120 expression acts as an unfavorable survival marker.
BRCA, SARC, and PRAD are the cancer types where C10orf120 Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.